HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$13.38
Day range
$13.25 - $14.04
Year range
$4.65 - $18.51
Market cap
1.36B USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.07M | — |
Operating expense | 19.38M | 28.56% |
Net income | -19.13M | -28.67% |
Net profit margin | -924.95 | — |
Earnings per share | -0.20 | -25.00% |
EBITDA | -21.73M | -20.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 204.82M | -15.33% |
Total assets | 217.60M | -12.45% |
Total liabilities | 16.62M | 47.47% |
Total equity | 200.98M | — |
Shares outstanding | 97.19M | — |
Price to book | 6.46 | — |
Return on assets | -24.74% | — |
Return on capital | -26.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -19.13M | -28.67% |
Cash from operations | -14.47M | -13.35% |
Cash from investing | 16.82M | 136.06% |
Cash from financing | 680.00K | -26.17% |
Net change in cash | 3.03M | 105.18% |
Free cash flow | -2.14M | 70.49% |
About
Founded
2015
Website
Employees
146
